CFDE Data Portal | Search LOC388282

	Label	Description
	LOC388282 Gene (Entity type)	ENSG00000187185 - uncharacterized LOC388282
	LOC388282 associations Collection (Entity type)	Associations for LOC388282_associations
	LOC388282 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE239844 crizotinib 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE162892 ISOX 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 6 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 6 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE120792 BRCA1 inhibition Interferons 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE258991 enzalutamide DK1 [Tursiops] 5 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LOC388282

ENSG00000187185 - uncharacterized LOC388282

LOC388282 associations

Associations for LOC388282_associations

LOC388282 associations.tsv

A file from IDG as part of the Harmonizome project

GSE239844 crizotinib 6 v 9 human up

A Gene Set from LINCS

GSE162892 ISOX 3 v 0 human dn

A Gene Set from LINCS

GSE108464 AZ-628 6 v 15 human dn

A Gene Set from LINCS

GSE146982 metformin 4 v 5 human dn

A Gene Set from LINCS

GSE108464 AZ-628 6 v 13 human dn

A Gene Set from LINCS

GSE120792 BRCA1 inhibition Interferons 1 v 0 human dn

A Gene Set from LINCS

GSE258991 enzalutamide DK1 [Tursiops] 5 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.